# EDGAR Filing Document

**Accession Number:** 0001769804
**File Stem:** 0001213900-23-019330
**Filing Date:** 2023-3
**Character Count:** 4528
**Document Hash:** ff103ab2fa24b815fee8fc448d7645b4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-23-019330.hdr.sgml**: 20230313

**ACCESSION NUMBER**: 0001213900-23-019330

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20230313

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230313

**DATE AS OF CHANGE**: 20230313

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Augmedix, Inc.
- **CENTRAL INDEX KEY:** 0001769804
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-BUSINESS SERVICES, NEC [7389]
- **IRS NUMBER:** 833299164
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40890
- **FILM NUMBER:** 23725559

**BUSINESS ADDRESS:**
- **STREET 1:** 111 SUTTER STREET, SUITE 1300
- **CITY:** SAN FRANCISC
- **STATE:** CA
- **ZIP:** 94104
- **BUSINESS PHONE:** 561-989-2208

**MAIL ADDRESS:**
- **STREET 1:** 111 SUTTER STREET, SUITE 1300
- **CITY:** SAN FRANCISC
- **STATE:** CA
- **ZIP:** 94104

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Malo Holdings Corp
- **DATE OF NAME CHANGE:** 20190305

?xml version="1.0" encoding="utf-8"?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d)**

**of the Securities Exchange Act of 1934**

**Date of report (Date of earliest event reported): March 13, 2023**

**AUGMEDIX, INC.**

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-40890** | **83-3299164** |
| **(State or other jurisdiction<br> of incorporation)** | **(Commission <br> File Number)** | **(I.R.S. Employer<br> Identification No.)** |

---

**111 Sutter Street, Suite 1300, San Francisco, California 94104**

**(Address of principal executive offices) (Zip Code)**

**Registrant's telephone number, including area code: (888) 669-4885**

**N/A**

**(Former name or former address, if changed since last report.)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, $0.0001 par value per share | AUGX | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 8.01. Other Events.** 

Augmedix, Inc. (the "Company") uses a number of different banks as part of its cash management practices including Silicon Valley Bank (SVB). U.S. regulators confirmed yesterday that SVB bank depositors will have access to all of their deposited funds today. Company management does not expect any disruption to the Company's operations from the FDIC takeover of SVB.

**Item 9.01. Financial Statements and Exhibits.**

(d) Exhibits.

---

| | |
|:---|:---|
| **Exhibit<br> No.** | **Description** |
| 104 | Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document. |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **AUGMEDIX, INC.** | **AUGMEDIX, INC.** |
| Dated: March 13, 2023 | By: | /s/ Paul Ginocchio |
|  |  | Paul Ginocchio |
|  |  | Chief Financial Officer |

---